GBA+ Consequences and Conclusions

Description: Dr. Cara Tannenbaum emphasizes the importance of GBA+ by providing examples of the specific dangers and potential unintended consequences of not doing GBA+.

Date: June 9, 2020

Duration: 00:03:05

Resolution: 1080p


Transcript

[An image of the GBA+ logo appears with the words "Gender-Based Analysis Plus"]

[A background with colourful bars appears with the title "Consequences and Conclusions". Then the subtitle "Dangers of Not Using GBA+" appears.]

[DR. CARA TANNENBAUM seated in her office, speaks to the camera. A colorful GBA+ symbol appears at the bottom left corner of the frame and her name (Dr. Cara Tannenbaum) and job title (Scientific Director, Institute of Gender and Health, Canadian Institutes of Health Research [CIHR]) appear to the right of the GBA+ symbol.]

[On the right of the screen, next to DR. CARA TANNENBAUM the word "Consequences" appears and then fades out.]

The unintended consequences of not doing properly is death. That sounds harsh, but it can kill people if we don't do this properly. And if you don't believe me, let me give you a drug example.

[On the right of the screen, next to DR. CARA TANNENBAUM the logo of the FDA appears and then fades out.]

The FDA, the Food and Drug Administration, in the United States did a deep dive on medications that were withdrawn from the market in the 1990s. Here's what they found: 10 medications were withdrawn from the market during that time period.

[A background with colourful bars appears with the word "Findings". The screen fades to reveal DR. CARA TANNENBAUM.]

They found that 8 out of the 10 drugs that were withdrawn from the market for killing people and causing severe side effects, these side effects only occurred in women.

[On the right of the screen, next to DR. CARA TANNENBAUM the fraction 8/10 appears in white text and then fades away.]

Now, of course, you might ask how can that be? How can it be that drugs were developed and got withdrawn from the market and women were the ones who suffered?

[On the right of the screen, next to DR. CARA TANNENBAUM dozens of white question marks pop onto screen and then disappear.]

Well, I can tell you how it was, and I can tell you how it came to be. But the bottom line is it's because nobody did an SGBA+ analysis on this.

[On the right of the screen, next to DR. CARA TANNENBAUM a green circle appears and the colourful GBA+ logo appears in the centre of the circle with the words "Gender-Based Analysis Plus" below.]

[A background with colourful bars appears with the words "Recap of Consequences". The screen fades to reveal DR. CARA TANNENBAUM.]

If you don't take the sex and gender-based analysis plus into account, you end up putting drugs on the market that are fatal in women.

[A horizontal green bar first appears on screen with the words "Sex" "Intersectionality" "Gender", followed by a series of other colourful bars in the shape of a flower featuring the words: "Education", "Sexual Orientation", "Income", "Culture", "Geography", "Race", "Religion", "Age", "Disability", "Ethnicity". These all rotate clockwise, and then a white skull and crossbones appears and covers the flower, which fades away.]

So I don't know what else to tell you. If you don't take sex and gender-based analysis plus into consideration, people do die—not always but they might.

[A background with colourful bars appears with the word "Conclusion". The screen fades to reveal DR. CARA TANNENBAUM.]

Remember those three things. One: get the data, divide it by subgroup, look if there's differences in frequency of use of medication, or effect of the environment, or whatever you're doing your GBA+ on.

[On the right of the screen, next to DR. CARA TANNENBAUM a large number 1 appears, followed by smaller white text that reads "Get the DATA and look for DIFFERENCES." The number 1 wipes to the right and the words disappear.]

Use data to look for differences but remember, that's only the first step.

You will not be doing a good GBA+ analysis if you can't tell me why differences exist.

[On the right of the screen, next to DR. CARA TANNENBAUM a large number 2 appears, followed by smaller white text that reads "Determine WHY the differences exist". The number 2 wipes to the right and the words disappear.]

Sometimes differences won't exist, but there's different pathways even to get to the same effect. So the "why people do what they do and how it affects them to lead to those statistics is the really exciting part for me about GBA+.

And then to be able to take the "why" and translate it into recommendations that make things better for everyone, even if it's not a one-size-fits-all,

[On the right of the screen, next to DR. CARA TANNENBAUM a large number 3 appears, followed by smaller white text that reads "Develop RECOMMENDATIONS". The number 3 wipes to the right and the words disappear.]

is why I think that Canada can lead in SGBA+ policy.

[A white map of Canada appears on the right to the screen, next to DR. CARA TANNENBAUM with the colourful GBA+ logo over top.]

[DR. CARA TANNENBAUM cuts out and a background with colourful bars appears and then disappears, and the Government of Canada logo appears.]


Features

COVID19

Information for Government of Canada employees: Coronavirus disease (COVID-19)

Updates for employees on COVID-19, telework, advisories, messages and resources to share.
COVID-19: Learning resources

COVID-19: Learning resourcesNew

Learning resources to support public servants during the COVID‑19 pandemic.

This website is continually being updated in response to your feedback.

Let us know what you think of it.
Which platform is your comment about:
Enter your email if you would like a reply:
Date modified: